HSA — authorised 31 July 2018
- Marketing authorisation holder: SHIONOGI INC
- Status: likely_approved
HSA authorised Mulpleta on 31 July 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 31 July 2018.
SHIONOGI INC holds the Singaporean marketing authorisation.